Clinical Trial Update: Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients [Phase 1]

View source ↗

Summary

This trial update reports a Phase 1 exploratory study of norepinephrine to prevent radiodermatitis in breast cancer patients, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: ProCertus BioPharm, Inc | Conditions: Radiodermatitis | Phase 1 | Status: TERMINATED